TG1042（腺病毒-干扰素-γ）在原发性皮肤B细胞淋巴瘤中的II期临床试验

资源简介

TG1042（腺病毒-干扰素-γ）在原发性皮肤B细胞淋巴瘤中的II期临床试验

【数据集背景】

本数据集源站标题为《TG1042 (Adenovirus-interferon-γ) in Primary Cutaneous B-cell Lymphomas: A Phase II Clinical Trial》。配套论文《TG1042 (Adenovirus-interferon-γ) in Primary Cutaneous B-cell Lymphomas: A Phase II Clinical Trial》发表于 PLoS ONE（2014），DOI：10.1371/journal.pone.0083670。源站首次发布：2014-02-24。

【数据内容】

源站原始描述：Rational While a variety of registered therapies exist for Cutaneous T Cell Lymphoma, no such therapy is available for Cutaneous B Cell Therapy. In this context we performed a phase II, open label, multicenter, non-comparative study to evaluate the efficacy and safety of repeated intra-lesional administrations of TG1042 (adenovirus-interferon-γ) in patients with relapsing primary cutaneous B-cell lymphomas (CBCL). Method Thirteen patients have been enrolled and received intralesional injections…

【数据结构与技术规格】

文件数 2 个，合计 739.48 KB。Checklist_S1.pdf：application/pdf，387.87 KB。Protocol_S1.pdf：application/pdf，351.61 KB。数据集 DOI：10.1371/journal.pone.0083670。

【主题与分类】

源站学科分类：Biological Sciences、Medicine。主题标签：genetics、Human genetics、Gene therapy、immunology、Immune cells、b cells、immunity、immunoregulation、immunotherapy、Immune response。

【适用方向】

源站学科分类标注为 Biological Sciences、Medicine。

【获取与许可】

源站页面：https://plos.figshare.com/articles/dataset/_TG1042_Adenovirus_interferon_947_in_Primary_Cutaneous_B_cell_Lymphomas_A_Phase_II_Clinical_Trial_/942908

使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。

规范引用：Dreno, Brigitte; Urosevic-Maiwald, Mirjana; Kim, Youn; Guitart, Joan; Duvic, Madeleine; Dereure, Olivier; et al. (2016). TG1042 (Adenovirus-interferon-γ) in Primary Cutaneous B-cell Lymphomas: A Phase II Clinical Trial. PLOS ONE. Dataset

【使用注意】

· 源站最后修改于 2023-06-03，引用时请注意版本时效。